XKRX:142280 (Korea (the Republic of))
Â
â‚©
3495.00
(+0.58%)
Dec 12
Business Description
Green Cross Medical Science Corp
ISIN : KR7142280007
Compare
Compare
Traded in other countries / regions
142280.Korea IPO Date
2014-12-17Description
Green Cross Medical Science Corp is a total medical device company. It is engaged in the blood glucose business, kidney hemodialysis business, and blood bag business with the application of its know-how in in-vitro diagnostics. The product portfolio offered by the organization includes diagnostic reagents, diagnostic instruments, blood bag, home medical devices, blood dialysis products and HbA1c/BGMS.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.67 | |||||
| Debt-to-EBITDA | 3.8 | |||||
| Interest Coverage | 0.44 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.22 | |||||
| Beneish M-Score | -2.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.6 | |||||
| 3-Year EBITDA Growth Rate | -9.6 | |||||
| 3-Year EPS without NRI Growth Rate | -60.8 | |||||
| 3-Year FCF Growth Rate | 49.5 | |||||
| 3-Year Book Growth Rate | -15.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.81 | |||||
| 9-Day RSI | 46.56 | |||||
| 14-Day RSI | 43.2 | |||||
| 3-1 Month Momentum % | -8.63 | |||||
| 6-1 Month Momentum % | -8.97 | |||||
| 12-1 Month Momentum % | -21.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.02 | |||||
| Quick Ratio | 0.6 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 68.98 | |||||
| Days Sales Outstanding | 77.88 | |||||
| Days Payable | 58.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -6.4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 13.79 | |||||
| Operating Margin % | 1.32 | |||||
| Net Margin % | 0.15 | |||||
| FCF Margin % | 0.23 | |||||
| ROE % | 0.41 | |||||
| ROA % | 0.16 | |||||
| ROIC % | 1.87 | |||||
| 3-Year ROIIC % | -154.42 | |||||
| ROC (Joel Greenblatt) % | 5.56 | |||||
| ROCE % | 6.75 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.75 | |||||
| PB Ratio | 1.95 | |||||
| Price-to-Tangible-Book | 1.99 | |||||
| Price-to-Free-Cash-Flow | 464.33 | |||||
| Price-to-Operating-Cash-Flow | 13.9 | |||||
| EV-to-EBIT | 32.38 | |||||
| EV-to-EBITDA | 14.63 | |||||
| EV-to-Revenue | 1.01 | |||||
| EV-to-FCF | 436.1 | |||||
| Price-to-GF-Value | 0.75 | |||||
| Price-to-Median-PS-Value | 0.59 | |||||
| Earnings Yield (Greenblatt) % | 3.09 | |||||
| FCF Yield % | 0.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Green Cross Medical Science Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 99,716.291 | ||
| EPS (TTM) (â‚©) | -51 | ||
| Beta | 0.83 | ||
| 3-Year Sharpe Ratio | -0.14 | ||
| 3-Year Sortino Ratio | -0.26 | ||
| Volatility % | 32.12 | ||
| 14-Day RSI | 43.2 | ||
| 14-Day ATR (â‚©) | 156.173185 | ||
| 20-Day SMA (â‚©) | 3598 | ||
| 12-1 Month Momentum % | -21.5 | ||
| 52-Week Range (â‚©) | 3090 - 6950 | ||
| Shares Outstanding (Mil) | 21.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Green Cross Medical Science Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Green Cross Medical Science Corp Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Green Cross Medical Science Corp Frequently Asked Questions
What is Green Cross Medical Science Corp(XKRX:142280)'s stock price today?
The current price of XKRX:142280 is â‚©3495.00. The 52 week high of XKRX:142280 is â‚©6950.00 and 52 week low is â‚©3090.00.
When is next earnings date of Green Cross Medical Science Corp(XKRX:142280)?
The next earnings date of Green Cross Medical Science Corp(XKRX:142280) is .
Does Green Cross Medical Science Corp(XKRX:142280) pay dividends? If so, how much?
Green Cross Medical Science Corp(XKRX:142280) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers